Abstract
There is substantial evidence regarding enhanced antitumor cytotoxicity of selected chemotherapeutic agents by appropriate heat exposure (40–44°C). Based upon these results, the integration of hyperthermia as an additional treatment modality given simultaneously with systemic chemotherapy is currently of considerable interest. Hyperthermia can be induced by alternating magnetic field and magnetic nanoparticles. Thus, we have used thermosensitive magnetoliposomes that contained superparamagnetic iron oxide nanoparticles and doxorubicin for in vitro and in vivo therapy of rat glioma C6. The results showed that magnetoliposomes can be specifically heated to 43°C (phase transition temperature of a used lipid composition) in a few minutes, and during this, the encapsulated doxorubicin is released in a controllable manner. The in vitro experiments showed that the cell viability decreased to 79.2% after heat treatment alone and to 47.4% for doxorubicin-loaded magnetoliposomes without application of alternating magnetic field, while the combined treatment resulted in 17.3% cell viability. Also, in vivo results demonstrated that magnetic drug targeting has a strong antiglioma effect with a tumor volume growth inhibition and complete regression. Such targeted delivery and controlled release of anticancer agents would provide clinical advantages compared with currently available methods.
Acknowledgement
The work was supported by the grant of Slovak grant agency VEGA 1/0810/18 .
References
1. Luciano R, Battafarano G, Saracino R, Rossi M, Perrotta A, Manco M, et al. New perspectives in glioblastoma: nanoparticles-based approaches. Curr Cancer Drug Targets 2017;17:203–20.10.2174/1568009616666160813190732Search in Google Scholar PubMed
2. De Felice F, Musio D, Cassese R, Gravina GL, Tombolini V. New approaches in glioblastoma multiforme: the potential role of immune-check point inhibitors. Curr Cancer Drug Targets 2017;17:282–9.10.2174/1568009616666160813183738Search in Google Scholar PubMed
3. Zimmermann U, Pilwat G. Organ specific application of drugs by means of cellular capsule systems. Z Naturforsch C 1976;31:732–6.10.1515/znc-1976-11-1219Search in Google Scholar PubMed
4. Babincová M, Babinec P, Bergemann C. High-gradient magnetic capture of ferrofluids: implications for drug targeting and tumour embolization. Z Naturforsch C 2001;56:909–11.10.1515/znc-2001-9-1039Search in Google Scholar PubMed
5. Babincová M, Altanerová V, Lampert M, Altaner C, Machová E, Šrámka M, et al. Site-specific in vivo targeting of magnetoliposomes using externally applied magnetic field. Z Naturforsch C 2000;55:278–81.10.1515/znc-2000-3-422Search in Google Scholar PubMed
6. Babincová M, Machová E. Magnetoliposomes may be useful for elimination of HIV from infected individuals. Z Naturforsch C 1998;53:935–6.10.1515/znc-1998-9-1027Search in Google Scholar PubMed
7. Babincová M, Cicmanec P, Altanerova V, Altaner C, Babinec P. AC magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapy. Bioelectrochemistry 2002;55:17–9.10.1016/S1567-5394(01)00171-2Search in Google Scholar PubMed
8. Babincová M, Altanerova V, Altaner C, Bergemann C, Babinec P. In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Trans Nanobiosci 2008;7:15–9.10.1109/TNB.2008.2000145Search in Google Scholar PubMed
9. Babincová M, Babincová N, Durdík S, Bergemann C, Sourivong P. Silencing by blasting: combination of laser pulse induced stress waves and magnetophoresis for siRNA delivery. Laser Phys Lett 2016;13:065601.10.1088/1612-2011/13/6/065601Search in Google Scholar
10. Durdík S, Krafčík A, Babincová M, Babinec P. Conceptual design of integrated microfluidic system for magnetic cell separation, electroporation, and transfection. Phys Med 2013;29:562–7.10.1016/j.ejmp.2012.11.003Search in Google Scholar PubMed
11. Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003;36:167–84.10.1088/0022-3727/36/13/201Search in Google Scholar
12. Safarik I, Safarikova M. Magnetically responsive nanocomposite materials for bioapplications. Solid State Phenom 2009;151:88–94.10.4028/www.scientific.net/SSP.151.88Search in Google Scholar
13. Safarik I, Pospiskova K, Horska K, Safarikova M. Potential of magnetically responsive (nano) biocomposites. Soft Matter 2012;8:5407–13.10.1039/c2sm06861cSearch in Google Scholar
14. Safarik I, Pospiskova K, Baldikova E, Safarikova M. Magnetically responsive biological materials and their applications. Adv Mater Lett 2016;7:254–61.10.5185/amlett.2016.6176Search in Google Scholar
15. Benda P, Lightbody J, Sato G, Levine L, Sweet W. Differentiated rat glial cell strain in tissue culture. Science 1968;161:370–1.10.1126/science.161.3839.370Search in Google Scholar PubMed
16. Bothun GD, Lelis A, Chen Y, Scully K, Anderson LE, Stoner MA. Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake. Nanomed-Nanotechnol 2011;7:797–805.10.1016/j.nano.2011.02.007Search in Google Scholar PubMed PubMed Central
17. Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int J Hyperthermia 1994;10:485–93.10.3109/02656739409009352Search in Google Scholar PubMed
18. Häfeli OU, Riffle JS, Harris-Shekhawat L, Carmichael-Baranauskas A, Mark F, Dalley JP, et al. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm 2009;6:1417–28.10.1021/mp900083mSearch in Google Scholar PubMed
19. Vrbovská H, Babincová M. Comparative analysis of synthetic and nutraceutical antioxidants as possible neuroprotective agents. Pharmazie 2016;71:724–6.Search in Google Scholar PubMed
20. Altanerova U, Babincova M, Babinec P, Benejova K, Jakubechova J, Altanerova V, et al. Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia. Int J Nanomed 2017;12:7923–36.10.2147/IJN.S145096Search in Google Scholar PubMed PubMed Central
©2018 Walter de Gruyter GmbH, Berlin/Boston
